SQLite Web: event

id

Primary key. TEXT

event_id

TEXT NOT NULL

watcher_id

TEXT

signal_type

TEXT NOT NULL

value

{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001628280-26-022971.txt","as_of":"2026-04-03T11:12:58.166696+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001628280-26-022971.txt","company":"Vir Biotechnology, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001628280-26-022971.txt","article_chars":2028,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_7bd267802c4bfb15","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001628280-26-022971.txt","content_type":"text/plain","enriched_at":"2026-04-03T13:53:07.795455+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001628280-26-022971.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001628280-26-022971.txt","source_event_id":"evt_0fcaeb5e4076","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"00408edabf6ee091","kind":"sec_filing","published_at":"20260402","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.9,"dates_mentioned":["2026-04-01","2026-04-02","2025-03-27"],"entities":[{"asset_class":"equity","name":"Vir Biotechnology, Inc.","relevance":"high","symbol":"VIR","type":"company"}],"event_type":"listing","information_gaps":["No prior state of ownership or number of shares held before the sale is provided."],"key_facts":["Form 4 filed on April 2, 2026.","22,000 shares sold at a weighted average price of $9.07.","Sales were made under a Rule 10b5-1 trading plan adopted on March 27, 2025."],"numeric_claims":[{"label":"Shares Sold","value":"22000"},{"label":"Weighted Average Price","value":"9.07"}],"primary_claim":"Vicki L. Sato sold 22,000 shares of Vir Biotechnology, Inc. at a weighted average price of $9.07 on April 1, 2026.","relevance_score":0.7,"sentiment":"neutral","source_quality":"medium","summary":"Vir Biotechnology, Inc. filed a Form 4 on April 2, 2026, disclosing the sale of shares by Vicki L. Sato under a trading plan.","topics":["SEC Filing","Insider Trading"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 Vir Biotechnology, Inc. \u00b7 Filed 20260402","ticker":"VIR","tickers":["VIR"],"title":"VIR filed 4","url":"https://www.sec.gov/Archives/edgar/data/1706431/0001628280-26-022971.txt"}

TEXT NOT NULL

threshold

TEXT

direction

TEXT

severity

TEXT

window

TEXT

source

TEXT NOT NULL

reason_trace

TEXT

dedupe_key

TEXT NOT NULL

throttle_s

INTEGER (default 0

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

event_store.db — signals

Update row sig_bb54b3eb37b7 in signals